RP Bio Inc. (KOSDAQ:314140)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,760.00
+150.00 (2.67%)
At close: May 29, 2026

RP Bio Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
13,2539,84814,1333,20816,8166,269
Short-Term Investments
8,7753,7774,7029,3501,4881,449
Trading Asset Securities
1,0091,002----
Cash & Short-Term Investments
23,03714,62618,83612,55818,3047,718
Cash Growth
27.59%-22.35%49.99%-31.39%137.16%-16.89%
Accounts Receivable
17,01918,49917,65919,99520,77321,320
Other Receivables
-111.4738.22353.66332.09112.17
Receivables
17,01918,61117,99720,34921,70521,433
Inventory
26,27124,13723,96234,10938,59022,569
Prepaid Expenses
-35.81212.71162.67177.3674.56
Other Current Assets
555.72171.39104.95535.722,266477.83
Total Current Assets
66,88357,58161,11267,71481,04352,272
Property, Plant & Equipment
93,09294,33695,92196,97588,72788,970
Long-Term Investments
66.0966.0966.0966.0966.0966.09
Other Intangible Assets
795.56756.47495.5335.15453.91538.48
Long-Term Deferred Tax Assets
1,3241,324741.131.49-318.05
Other Long-Term Assets
2,5292,1641,1331,0962,7981,573
Total Assets
164,690156,256159,499166,218173,158143,737
Accounts Payable
24,05919,42917,33020,73729,78124,529
Accrued Expenses
-1,9271,3341,7412,0101,779
Short-Term Debt
19,23516,00025,00025,00034,87336,826
Current Portion of Leases
256.76309.07601.391,007676.85651.95
Current Income Taxes Payable
232.5446.11252.0725.14710.76218.3
Other Current Liabilities
6,2556,2946,6588,98610,5797,385
Total Current Liabilities
50,03944,40451,17557,49678,63071,389
Long-Term Leases
3,0673,1394,5934,7742,6352,858
Pension & Post-Retirement Benefits
1,706983.57912.89616.03--
Long-Term Deferred Tax Liabilities
----237.08-
Other Long-Term Liabilities
554.32531.73515.29584.61519.18501.27
Total Liabilities
55,36649,05857,19663,47182,02174,748
Common Stock
4,3334,3334,3334,3334,0973,294
Additional Paid-In Capital
65,34965,34965,34965,34658,82637,431
Retained Earnings
39,70537,57932,68433,12828,26824,160
Treasury Stock
-81.47-81.47-81.47-81.47-81.47-81.47
Comprehensive Income & Other
17.8817.8817.8821.5627.33123.52
Total Common Equity
109,324107,198102,303102,74791,13764,927
Shareholders' Equity
109,324107,198102,303102,74791,13768,989
Total Liabilities & Equity
164,690156,256159,499166,218173,158143,737
Total Debt
22,55919,44830,19430,78138,18540,336
Net Cash (Debt)
478.15-4,821-11,359-18,223-19,881-32,618
Net Cash Per Share
55.26-557.39-1314.76-1950.62-2791.65-4962.17
Filing Date Shares Outstanding
8.668.658.658.658.186.57
Total Common Shares Outstanding
8.668.658.658.658.186.57
Working Capital
16,84413,1779,93710,2182,413-19,117
Book Value Per Share
12618.1412393.0311827.1611878.4311145.289877.25
Tangible Book Value
108,528106,441101,808102,41190,68364,388
Tangible Book Value Per Share
12526.3212305.5811769.8811839.6811089.779795.34
Land
17,33317,33315,44115,44115,44115,441
Buildings
63,55563,55562,86657,48756,36755,187
Machinery
49,40849,34255,98554,55846,90444,016
Construction In Progress
916.33671.567982,264832.74523.48